Novel strategies for improving the anticancer efficacy of salinomycin and LCN2 siRNA against triple negative breast cancer: implication of targeted/combinatorial drug regimens
HITESH KUMAR, JSS COLLEGE OF PHARMACY MYSURU
2023
Novel strategies for improving the anticancer efficacy of salinomycin and LCN2 siRNA against triple negative breast cancer: implication of targeted/combinatorial drug regimens
Novel strategies for improving the anticancer efficacy of therapeutic nucleic acids against breast cancer stem cells: implication of targeted/combinatorial drug regimens.
Funding Agency : SERB DST
Completed
PI
5523000
2018 -
2021
Novel strategies for improving the anticancer efficacy of therapeutic nucleic acids against breast cancer stem cells: implication of targeted/combinatorial drug regimens.